Cerebral, Meningeal Biopsy by Flexible Endoscopy in Patients Without Neurological Diagnosis

Neurological Disease Clinical Trial

Official title:

Cerebral, Meningeal Biopsy by Flexible Endoscopy in Patients Without Neurological Diagnosis

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01073280
• Other study ID #: NCT150210
• Status: Recruiting
• Phase: N/A
• First received: February 22, 2010
• Last updated: February 22, 2010
• Start date: November 2009
• Est. completion date: October 2010

Study information

• Verified date: February 2010
• Source: Universidad Autonoma de San Luis Potosí
• Contact: Jesus Martin Sanchez Aguilar, surgeon
• Email: jemarsan7[@]hotmail.com
• Is FDA regulated: No
• Health authority: United States: Food and Drug Administration
• Study type: Observational

Clinical Trial Summary

The investigators will take cerebral and subarachnoid biopsy by flexible endoscopy in patients without neurological findings. The investigators will use retrospective and prospective patients.

Description:

Test the useful of the flexible endoscopy in patients without neurological diagnosis.

Developed a diagnosis method for idiopathic neurological findings.

Compare the cerebral and subarachnoid biopsy each other

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 40
• Est. completion date: October 2010
• Est. primary completion date: January 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A to 85 Years

Eligibility

Inclusion Criteria:

• patients with neurological disease and with out diagnosis

Exclusion Criteria:

• death of the patient

• patients with neurological diagnosis

Study Design

Observational Model: Case-Crossover, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Nervous System Diseases
• Neurological Disease

Intervention

Procedure:
• cerebral flexible endoscopy
The investigators will make a burrhole in the precoronal suture introducing the flexible endoscope taking a cerebral and a basal meningeal biopsy

Locations

Country	Name	City	State
Mexico	Hospital Central Dr. Ignacio Morones Prieto	San Luis Potosi

Sponsors (1)

Lead Sponsor	Collaborator
Universidad Autonoma de San Luis Potosí

Country where clinical trial is conducted

Mexico, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Test the useful of the cerebral and subarachnoid biopsy by flexible endoscopy in patients without neurological findings		2 weeks	No
Secondary	Developed a diagnosis method for idiopathic neurological findings. Compare the cerebral and subarachnoid biopsy each other		2 weeks	No